Cancer immunology expert and former AACR president Elizabeth Jaffee, MD, FAACR, discusses the latest progress in the research on...
“Where is the field of cancer research going?” posed Robert Vonderheide, MD, DPhil, as he welcomed attendees to “AACR...
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have...
The era of targeted cancer therapy has fundamentally transformed the way several cancers are treated and has provided new...
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
Although not common, a cancer diagnosis during pregnancy or the onset of a pregnancy while a woman is receiving...
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...